PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
-19.9%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$3.96B
AUM Growth
+$3.96B
(-22%)
Cap. Flow
+$38.2M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
53.12%
Holding
122
New
24
Increased
37
Reduced
35
Closed
5
Top Buys
| 1 |
JD.com
JD
|
$102M |
| 2 |
GE Aerospace
GE
|
$79.3M |
| 3 |
Huazhu Hotels Group
HTHT
|
$75.9M |
| 4 |
Trip.com Group
TCOM
|
$70.1M |
| 5 |
Lam Research
LRCX
|
$63.8M |
Top Sells
| 1 |
ZTO Express
ZTO
|
$105M |
| 2 |
Meta Platforms (Facebook)
META
|
$94.3M |
| 3 |
Alibaba
BABA
|
$90.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$80.9M |
| 5 |
Gilead Sciences
GILD
|
$71.2M |
Sector Composition
| 1 | Consumer Discretionary | 25.44% |
| 2 | Technology | 22.44% |
| 3 | Industrials | 16.51% |
| 4 | Communication Services | 15.61% |
| 5 | Healthcare | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dianthus Therapeutics
DNTH
$759M
| $1.64M | 0.04% |
260,938
+52,900
| +25% | +$332K |
|
77
Alkermes
ALKS
$4.78B
| $1.64M | 0.04% |
113,399
+57,514
| +103% | +$829K |
|
78
PayPal
PYPL
$67.1B
| $1.57M | 0.04% |
16,437
| – | – |
|
79
Sangamo Therapeutics
SGMO
$157M
| $1.57M | 0.04% |
245,840
+49,575
| +25% | +$316K |
|
80
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.54M | 0.04% |
+771,386
| New | +$1.54M |
|
|
AERI
81
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.54M | 0.04% |
113,842
| – | – |
|
82
Pacific Biosciences
PACB
$393M
| $1.53M | 0.04% |
499,696
+252,221
| +102% | +$772K |
|
83
Bio-Rad Laboratories Class A
BIO
$8.06B
| $1.46M | 0.04% |
+4,175
| New | +$1.46M |
|
84
Arcus Biosciences
RCUS
$1.13B
| $1.44M | 0.04% |
103,740
| – | – |
|
85
Oracle
ORCL
$635B
| $1.42M | 0.04% |
29,418
| – | – |
|
86
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.42M | 0.04% |
13,021
-2,720
| -17% | -$296K |
|
87
Cisco
CSCO
$274B
| $1.4M | 0.04% |
35,700
| – | – |
|
88
Prothena Corp
PRTA
$441M
| $1.37M | 0.03% |
128,223
-12,720
| -9% | -$136K |
|
89
Apple
AAPL
$3.45T
| $1.36M | 0.03% |
5,362
-1,686
| -24% | -$429K |
|
90
Alector
ALEC
$238M
| $1.36M | 0.03% |
56,240
-36,693
| -39% | -$885K |
|
91
Autohome
ATHM
$3.42B
| $1.25M | 0.03% |
17,640
| – | – |
|
92
Adaptive Biotechnologies
ADPT
$2.01B
| $1.24M | 0.03% |
+44,782
| New | +$1.24M |
|
93
Denali Therapeutics
DNLI
$2.23B
| $1.24M | 0.03% |
+70,793
| New | +$1.24M |
|
94
Wave Life Sciences
WVE
$1.53B
| $1.18M | 0.03% |
126,185
+57,228
| +83% | +$536K |
|
95
Fulcrum Therapeutics
FULC
$351M
| $1.14M | 0.03% |
95,533
-43,234
| -31% | -$516K |
|
96
Ovid Therapeutics
OVID
$91M
| $1.14M | 0.03% |
382,935
+76,789
| +25% | +$229K |
|
|
ORTX
97
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.05M | 0.03% |
+138,827
| New | +$1.05M |
|
98
Zimmer Biomet
ZBH
$21B
| $1.04M | 0.03% |
+10,279
| New | +$1.04M |
|
99
Intellia Therapeutics
NTLA
$1.22B
| $1.02M | 0.03% |
83,737
+17,567
| +27% | +$215K |
|
100
Analog Devices
ADI
$124B
| $961K | 0.02% |
10,720
| – | – |
|